FOXO4-DRI vs Epitalon
FOXO4-DRI is mainly studied for longevity (experimental context), cellular senescence. while Epitalon is studied for longevity, sleep, circadian rhythm. The difference is in the mechanism and the evidence, not in which is "better": it depends on the goal.
| FOXO4-DRI | Epitalon | |
|---|---|---|
| Category | Longevity/Cellular | Longevity/Cellular |
| Studied for | Longevity (experimental context), cellular senescence. | Longevity, sleep, circadian rhythm. |
| How it acts | An experimental senolytic peptide studied for its relationship with clearance of senescent cells in preclinical models. | A peptide studied for its relationship with telomerase regulation and rhythms associated with cellular aging. |
| Evidence level | Preclinical evidence only | Limited human evidence |
How they differ
Although sometimes mentioned together, FOXO4-DRI and Epitalon do not target the same thing. FOXO4-DRI: An experimental senolytic peptide studied for its relationship with clearance of senescent cells in preclinical models. Epitalon: A peptide studied for its relationship with telomerase regulation and rhythms associated with cellular aging.
See full entry: FOXO4-DRI → · See full entry: Epitalon →
Want to truly understand it, not memorize it?
The course explains each peptide at a university level: how it acts, what outcomes are studied, what it combines with and when to pause. No doses: the protocol is defined by a professional.
See the course → Start with the free test →Frequently asked questions
What is the main difference between FOXO4-DRI and Epitalon?
FOXO4-DRI targets longevity (experimental context), cellular senescence. and Epitalon targets longevity, sleep, circadian rhythm. They act through different pathways, so the choice depends on your goal, not on which is "stronger".
Can they be studied together?
Combinations are studied by goal in the literature, but combining is not just adding: it changes the safety profile. What to combine and how is decided with a professional; here we only explain what each is studied for.
Which has more human evidence?
Based on the references we verified, Epitalon has more human studies of this pair. Each one's evidence level is in the table above, and the references with their PMID are at the end.
Other comparisons
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for FOXO4-DRI vs Epitalon or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
References
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Agingpreclinical Cell · 2017 · PMID 28340339 →
- Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytespreclinical Front Bioeng Biotechnol · 2021 · PMID 33996787 →
- FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged micepreclinical Aging (Albany NY) · 2020 · PMID 31959736 →
- FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cellspreclinical Exp Gerontol · 2024 · PMID 39025385 →
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Propertiesreview Int J Mol Sci · 2025 · PMID 40141333 →
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activitypreclinical Biogerontology · 2025 · PMID 40908429 →
- Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR micepreclinical Biogerontology · 2003 · PMID 14501183 →
- Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic micepreclinical Int J Cancer · 2002 · PMID 12209581 →
Educational content. It does not include doses, protocols or preparation: that is defined by a professional.